Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$794M
| $3.71M | ﹤0.01% |
209,260
+50,730
| +32% | +$964K |
|
3077
Corcept Therapeutics
CORT
$12.4B
| $3.71M | ﹤0.01% |
277,854
+259,260
| +1,394% | +$3.43M |
|
3078
Crane NXT
CXT
$2.97B
| $3.71M | ﹤0.01% |
147,969
+41,037
| +38% | +$1.22M |
|
3079
Interactive Brokers
IBKR
$41.7B
| $3.71M | ﹤0.01% |
271,384
-176,972
| -39% | -$2.36M |
|
3080
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $3.71M | ﹤0.01% |
169,000
-43,700
| -21% | -$1.02M |
|
|
IPHS
3081
DELISTED
Innophos Holdings, Inc.
IPHS
| $3.7M | ﹤0.01% |
150,908
+73,361
| +95% | +$2.23M |
|
|
BRSL
3082
CALL
Brightstar Lottery PLC
BRSL
$2.15B
| $3.7M | ﹤0.01% |
252,900
-41,400
| -14% | -$684K |
|
3083
VanEck IG Floating Rate ETF
FLTR
$3.04B
| $3.69M | ﹤0.01% |
149,645
+108,828
| +267% | +$2.73M |
|
3084
PUT
GameStop
GME
$8.37B
| $3.69M | ﹤0.01% |
1,170,800
-1,125,600
| -49% | -$3.94M |
|
3085
PUT
Madison Square Garden
MSGS
$9.8B
| $3.69M | ﹤0.01% |
19,348
-36,732
| -65% | -$7.15M |
|
3086
Kilroy Realty
KRC
$4.22B
| $3.69M | ﹤0.01% |
58,691
-852,081
| -94% | -$58.3M |
|
3087
PUT
Apollo Global Management
APO
$83.1B
| $3.69M | ﹤0.01% |
150,200
+53,300
| +55% | +$1.53M |
|
3088
ProShares UltraShort Dow 30
DXD
$42.7M
| $3.69M | ﹤0.01% |
20,827
+12,441
| +148% | +$1.99M |
|
|
GBT
3089
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.69M | ﹤0.01% |
89,800
+9,800
| +12% | +$367K |
|
3090
CALL
Sinclair Inc
SBGI
$1.07B
| $3.68M | ﹤0.01% |
139,600
-8,300
| -6% | -$242K |
|
|
ARCH
3091
PUT
DELISTED
Arch Resources, Inc.
ARCH
| $3.68M | ﹤0.01% |
44,300
+9,300
| +27% | +$827K |
|
3092
Artisan Partners
APAM
$2.99B
| $3.67M | ﹤0.01% |
166,240
+135,657
| +444% | +$3.62M |
|
3093
PUT
NOV
NOV
$7.54B
| $3.67M | ﹤0.01% |
143,000
-118,300
| -45% | -$4.09M |
|
3094
VanEck High Yield Muni ETF
HYD
$4.4B
| $3.67M | ﹤0.01% |
+60,168
| New | +$3.67M |
|
|
CLVS
3095
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $3.67M | ﹤0.01% |
204,200
+77,100
| +61% | +$1.58M |
|
3096
Oxford Industries
OXM
$543M
| $3.67M | ﹤0.01% |
51,588
-2,611
| -5% | -$212K |
|
3097
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$139M
| $3.67M | ﹤0.01% |
105,555
+77,955
| +282% | +$3.03M |
|
3098
Eaton
ETN
$175B
| $3.66M | ﹤0.01% |
53,261
-222,565
| -81% | -$16.6M |
|
|
PDS
3099
Precision Drilling
PDS
$1.09B
| $3.66M | ﹤0.01% |
105,222
+15,553
| +17% | +$770K |
|
3100
iShares Biotechnology ETF
IBB
$9.73B
| $3.65M | ﹤0.01% |
37,902
-101,251
| -73% | -$10.7M |
|
Similar funds
Ken Griffin's Q4 2018 Portfolio in Review
As of Q4 2018, Ken Griffin held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Ken Griffin withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Assurant worth $99.4M.
- Ken Griffin's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Ken Griffin added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Ken Griffin's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Ken Griffin fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Ken Griffin's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Ken Griffin opened 1,236 new positions and closed 1,371 in Q4 2018.
- Ken Griffin's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.